BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 18, 2001
View Archived Issues
GT-160-246 as a promising approach to C. difficile colitis
Read More
Phase IIb clinical trial of ATL-1251 to begin in U.K. in IBS patients
Read More
Proof of principle demonstrated in phase II studies for novel cardiology candidate therapeutic
Read More
Bayer and GeneData extend successful genomics-based antibiotic discovery collaboration
Read More
Muscarinic M3 antagonist YM-905 studied in experimental models of IBS symptoms
Read More
Castor oil component demonstrates both pro- and antiinflammatory properties
Read More
AnorMED makes significant strides in development programs
Read More
AJ-2615, a dual calcium antagonist and alpha1-adrenoceptor blocker: implications for CABG patients
Read More
Solvay identifies new atypical antipsychotic candidate
Read More
Long-term AICAR has beneficial metabolic and cardiovascular effects in rat IRS model
Read More
Methods and compositions for inflammatory diseases disclosed by GSK
Read More
Synthesis and use of new macrolides described by Pfizer
Read More
Anti-TNF agents in development at Sanofi-Synthelabo
Read More
Inhibitors of cysteine proteases of the ICE/ced-3 family identified by Idun
Read More
Shionogi patents potent new antitumor agents useful against solid tumors
Read More
New ADIR compounds useful for improving endothelial dysfunction
Read More
Oxazolidinone antibacterial agents discovered by Abbott
Read More
Clinical development update presented by Novuspharma for second quarter
Read More